Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT00374140. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a phase II, two-stage, open-label, single-agent study of the experimental drug RAD001 (everolimus) in patients with previously treated small cell lung cancer. RAD001 will be administered orally at a dose of 10 mg daily.
Study identification
- NCT ID
- NCT00374140
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2006
- Primary completion
- Nov 30, 2008
- Completion
- May 31, 2012
- Last update posted
- Oct 18, 2017
2006 – 2012
United States locations
- U.S. sites
- 19
- U.S. states
- 2
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UPMC Cancer Center - Teramana Cancer Center - Steubenville | Steubenville | Ohio | 43952 | — |
| UPMC Cancer Center - Beaver | Beaver | Pennsylvania | 15009 | — |
| UPMC Cancer Center - Clairton | Clairton | Pennsylvania | 15025 | — |
| UPMC Cancer Center - Arnold Palmer Pavilion - Greensburg | Greensburg | Pennsylvania | 15601 | — |
| UPMC Cancer Center - Oakbrook Commons - Greensburg | Greensburg | Pennsylvania | 15601 | — |
| UPMC Cancer Center - Indiana | Indiana | Pennsylvania | 15701 | — |
| UPMC Cancer Center - John P. Murtha Pavilion - Johnstown | Johnstown | Pennsylvania | 15901 | — |
| UPMC Cancer Center - McKeesport | McKeesport | Pennsylvania | 15132 | — |
| UPMC Cancer Center - Monroeville | Monroeville | Pennsylvania | 15146 | — |
| UPMC Cancer Center - Sewickley Medical Oncology/Hematology Group | Moon Township | Pennsylvania | 15108 | — |
| UPMC Cancer Center - New Castle | New Castle | Pennsylvania | 16105 | — |
| UPMC Cancer Center - St. Margaret's | Pittsburgh | Pennsylvania | 15215 | — |
| UPMC Cancer Center - Mercy | Pittsburgh | Pennsylvania | 15219 | — |
| University of Pittsburgh Cancer Institute - Hillman Cancer Center | Pittsburgh | Pennsylvania | 15232 | — |
| UPMC Cancer Center - Passavant | Pittsburgh | Pennsylvania | 15237 | — |
| UPMC Cancer Center - Upper St. Clair | Pittsburgh | Pennsylvania | 15241 | — |
| UPMC Cancer Center - Uniontown | Uniontown | Pennsylvania | 15401 | — |
| UPMC Cancer Center - Washington | Washington | Pennsylvania | 15301 | — |
| UPMC Cancer Center - North Hills | Wexford | Pennsylvania | 15090 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00374140, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 18, 2017 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00374140 live on ClinicalTrials.gov.